Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ASND is expected to report earnings to fall 66.53% to 94 cents per share on November 11

Ascendis Pharma A/S ASND Stock Earnings Reports

Q3'26

Est.

$0.95

Q2'26

Beat

by $1.32

Q1'26

Beat

by $0.09

Q4'25

Missed

by $0.40

Q3'25

Missed

by $0.72

The last earnings report on August 13 showed earnings per share of $2.83, beating the estimate of $1.51. With 147.84K shares outstanding, the current market capitalization sits at 16.61B.

View a ticker or compare two or three

ASND

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days